case_images: PMC9892048_01
case_images: Percutaneous intubation procedure. (A) Atrial septal puncture. (B) Insertion of the snare. (C) Jugular guide wire creates a passage in the left atrium. (D) Drainage tube placement.
case_images: fcvm-10-1093794-g001.jpg
case_images: PMC9892048_01_fcvm-10-1093794-g001.jpg
case_images: F1
case_images: A guide wire was inserted through the right femoral vein puncture to achieve right heart catheterization under the guidance of ultrasound and digital subtraction angiography (DSA) (Figure 1A, and a snare was placed in the right atrium along the femoral vein guide wire (Figure 1B). The catheter was delivered through the right jugular vein, captured by a snare, and placed into the left atrium along the femoral vein guide wire (Figure 1C). A drainage tube was placed using the guide wire approach to establish a drainage path through the jugular vein, superior vena cava, right atrium, and atrial septum to the left atrium (Figure 1D).
case_images: Lab rest results during extra- ventricular assist device (VAD) support. (A) Blood compatibility. PLT, platelet; RBC, red blood cell; WBC, white blood cell. (B) Anticoagulation management. ACT, active clotting time (s); APTT, activated partial thromboplastin time (s); D-Dimer (mg/L).
case_images: fcvm-10-1093794-g002.jpg
case_images: PMC9892048_01_fcvm-10-1093794-g002.jpg
case_images: F2
case_images: No hemolysis-related complications occurred (Figure 2A), and liver and kidney function were unaffected (Table 1). Heparin was used for anticoagulation therapy to maintain the target activated coagulation time (ACT) between 180 and 220 s and maintain the target activated partial thromboplastin time (APTT) between 40 and 55 s (Figure 2B).